Curis, Inc.

US$0.91As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CRISHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (57.84%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 3.25
PE TTM —
TSR TTM (96.96%)
Mkt cap US$3.721M
ROIC (185.56%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.992
9.43%
122.67%
Hold 8|12|10|3|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.02
0.02
0.02
16.15%
11.29%
17.67%
10.47%
Revenue$M
0.312
0.308
0.320
0.318
14.54%
8.15%
11.24%
5.10%
Peers (US$3.721M)
Cap (US$)
PE
3.756M
—
Capital
TTM
5Y
10Y
Leveragex
0.564
(0.016)
(0.022)
EBIT/Intx
5.837
0.210
0.210
Own earn%
189.27
(83.15)
(74.84)
Sh yield%
25.26
14.58
13.71
Owners
Insiders/Inst%
1.78
70.94
Short interest%
0.94
SBC / revenue%
2.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
3–9
$1 testx
—
Incr. ROIC%
1